Install
News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals
- 32articles · 30d
- 2+ day agolatest article
- Aug 17, 2026earliest in window
- 91%with images
- 135avg words
- Medical 30
- Health 23
- Health & Wellness 23
- Business & Industrial 9
- Science & Technology 4
- Economy, Business & Finance 3
- Finance & Business 2
- Human Interest 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence
3+ day, 13+ hour ago (159+ words) PharmaDispatch Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence A Sydney company has become the first in Australia to earn a manufacturing licence for viral vectors, a milestone it says strengthens the nation's capacity to make advanced…...
GSK therapy becomes first biologic subsidised for Australians with uncontrolled COPD
1+ week, 5+ day ago (161+ words) PharmaDispatch GSK therapy becomes first biologic subsidised for Australians with uncontrolled COPD Lung Foundation Australia chief executive Mark Brooke said, "Living with uncontrolled COPD can be incredibly challenging. Managing breathlessness, infections and repeated flare-ups can be a source of ongoing…...
Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter
1+ week, 6+ day ago (131+ words) PharmaDispatch Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter Astellas Australia has appointed Guillaume Pfeiffer as its new general manager, bringing more than two decades of experience across specialty medicines, rare diseases, oncology and advanced therapies…...
Entropy takes TRP-8803 to the US in head-to-head depression trial - BioPharmaDispatch
2+ week, 4+ day ago (143+ words) Entropy takes TRP-8803 to the US in head-to-head depression trial PharmaDispatch Entropy takes TRP-8803 to the US in head-to-head depression trial Entropy Neurodynamics has signed an agreement with the University of California, San Francisco, to develop a US Phase 2 trial…...